<p>Pyrogram trace obtained after analysis of a sample with –/TA (TA6/TA7) genotype when analyzed for allele variant *28.</p>

Pyrogram trace obtained after analysis of a sample with –/TA (TA6/TA7) genotype when analyzed for allele variant *28.
<p>Pyrogram trace obtained after analysis of samples with a G/G genotype when analyzed for allele variant *6.</p>

Pyrogram trace obtained after analysis of samples with a G/G genotype when analyzed for allele variant *6.
<p>Pyrogram trace obtained after analysis of a sample with –/– (TA6/TA6) genotype when analyzed for allele variant *28.</p>

Pyrogram trace obtained after analysis of a sample with –/– (TA6/TA6) genotype when analyzed for allele variant *28.
Illustrations of the <em>therascreen </em>UGT1A1 assays.
Illustrations of the therascreen UGT1A1 assays.
<p>Pyrogram trace obtained after analysis of a sample with –/TA (TA6/TA7) genotype when analyzed for allele variant *28.</p>
<p>Pyrogram trace obtained after analysis of samples with a G/G genotype when analyzed for allele variant *6.</p>
<p>Pyrogram trace obtained after analysis of a sample with –/– (TA6/TA6) genotype when analyzed for allele variant *28.</p>
Illustrations of the <em>therascreen </em>UGT1A1 assays. The sequence indicated is the analyzed sequence with polymorphic nucleotides indicated by square brackets or slash. Part of the TA repeats analyzed with the UGT1A1 *28 assay are covered by the sequencing primer. FP, FPB: Forward PCR primers (B indicates biotinylation); RP, RPB: Reverse PCR primers (B indicates biotinylation); Seq: Sequencing primers.